Skip to content
DNA concept art
Webinar

Feedback from Liquid Biopsy laboratories using pan-mutation panels for precision analysis with Crystal Digital PCR®

In this webinar, Sahbi Ben Kilani, PhD, Global Field Application Scientist Manager, shared real-world experiences where users pushed multiplexing capabilities and sensitivity boundaries. Using pan-mutation panels, they provided valuable insights into how this cutting-edge technology is transforming clinical research.

Learn more about Crystal Flex Assays and Nio® Digital PCR by downloading our brochures.

Highlights

  • High Sensitivity & Multiplexing Capabilities: Stilla’s technologies offer high sensitivity and allow multiplexing with up to 21 targets in a single assay, such as our ESR1 18-plex assay.
  • Ease of Use: Nio® Digital PCR provides a simplified workflow with minimal hands-on time, using a single instrument and one consumable per sample. This makes it suitable for routine testing in research laboratories.
  • Crystal Flex Probes® Technology: simplifies multiplexing by enabling the detection of multiple targets with high specificity, making it perfect for low-concentration samples like liquid biopsy.